Literature DB >> 11703536

Tissue granuloma structure-function in experimental visceral leishmaniasis.

H W Murray1.   

Abstract

In experimental visceral leishmaniasis in normal mice (BALB/c, C57BL/6) acquired resistance to Leishmania donovani, a protozoan which targets tissue macrophages, depends upon T cells, Th1 cell-type cytokine generation and activated mononuclear phagocytes. In the intact host, initial control and eventual resolution of L. donovani hepatic infection in normal mice is expressed by and accomplished within well-formed, mature tissue granulomas. In the liver, these immunologically active, inflammatory structures are assembled around a core of fused, parasitized resident macrophages (Kupffer cells) which come to be encircled by both cytokine-secreting T cells and influxing leishmanicidal blood monocytes. This pro-host defense granuloma structure-function relationship, in which histologically mature granulomas provide the microenvironment for intracellular L. donovani killing, however, is only one of seven which have been identified through experimental modifications in this model. This report reviews these structure-function relationships and illustrates the broad spectrum of additional possible responses. These responses range from structurally intact granulomas which provide no antileishmanial function (the 'ineffective' granuloma), to enlarged granulomas which show enhanced parasite killing (the 'hypertrophied' granuloma), to effective antileishmanial activity in the absence of any tissue reaction (the 'invisible' granuloma).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703536      PMCID: PMC2517779          DOI: 10.1046/j.1365-2613.2001.00199.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  70 in total

1.  Characterization of tumor necrosis factor-deficient mice.

Authors:  M W Marino; A Dunn; D Grail; M Inglese; Y Noguchi; E Richards; A Jungbluth; H Wada; M Moore; B Williamson; S Basu; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Cytokines in the induction and expression of T-cell-mediated granuloma formation and protection in the murine model of listeriosis.

Authors:  M E Mielke; C Peters; H Hahn
Journal:  Immunol Rev       Date:  1997-08       Impact factor: 12.988

Review 3.  Chemokines--chemotactic cytokines that mediate inflammation.

Authors:  A D Luster
Journal:  N Engl J Med       Date:  1998-02-12       Impact factor: 91.245

4.  Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis.

Authors:  H W Murray
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

5.  Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.

Authors:  P C Melby; Y Z Yang; J Cheng; W Zhao
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.

Authors:  C R Engwerda; M L Murphy; S E Cotterell; S C Smelt; P M Kaye
Journal:  Eur J Immunol       Date:  1998-02       Impact factor: 5.532

7.  The importance of TGF-beta in murine visceral leishmaniasis.

Authors:  M E Wilson; B M Young; B L Davidson; K A Mente; S E McGowan
Journal:  J Immunol       Date:  1998-12-01       Impact factor: 5.422

8.  Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani.

Authors:  M L Murphy; S E Cotterell; P M Gorak; C R Engwerda; P M Kaye
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

9.  Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.

Authors:  H W Murray; J Hariprashad; R L Coffman
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

10.  Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice.

Authors:  A P Taylor; H W Murray
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

View more
  83 in total

1.  Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis.

Authors:  Henry W Murray; Kathleen C Flanders; Debra D Donaldson; Joseph P Sypek; Philip J Gotwals; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

2.  Responses to Leishmania donovani in mice deficient in interleukin-12 (IL-12), IL-12/IL-23, or IL-18.

Authors:  Henry W Murray; Christine W Tsai; Jianguo Liu; Xiaojing Ma
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidate.

Authors:  Karin Seifert; Christiane Juhls; Francisco J Salguero; Simon L Croft
Journal:  Antimicrob Agents Chemother       Date:  2015-06-08       Impact factor: 5.191

4.  The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani.

Authors:  Sanjay Varikuti; Greta Volpedo; Noushin Saljoughian; Omar M Hamza; Gregory Halsey; Nathan M Ryan; Bren E Sedmak; Gabriella R Seidler; Tracey L Papenfuss; Steve Oghumu; Abhay R Satoskar
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

5.  Immunohistochemical study of hepatic fibropoiesis associated with canine visceral leishmaniasis.

Authors:  Igor M V M Madeira; Debora M O Pereira; Aline A Sousa; Cesar A Vilela; Izabela F G Amorim; Marcelo V Caliari; Carolina C Souza; Wagner L Tafuri
Journal:  Int J Exp Pathol       Date:  2016-05-31       Impact factor: 1.925

6.  Previous exposure to a low infectious dose of Leishmania major exacerbates infection with Leishmania infantum in the susceptible BALB/c mouse.

Authors:  Catherine S Nation; Blaise Dondji; Gabrielle A Stryker
Journal:  Parasitol Res       Date:  2012-04-04       Impact factor: 2.289

7.  Regulatory actions of Toll-like receptor 2 (TLR2) and TLR4 in Leishmania donovani infection in the liver.

Authors:  Henry W Murray; Yunhua Zhang; Yan Zhang; Vanitha S Raman; Steven G Reed; Xiaojing Ma
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

8.  Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.

Authors:  June Ghosh; Shantanabha Das; Rajan Guha; Debopam Ghosh; Kshudiram Naskar; Anjan Das; Syamal Roy
Journal:  J Lipid Res       Date:  2012-10-10       Impact factor: 5.922

9.  Dynamic imaging of experimental Leishmania donovani-induced hepatic granulomas detects Kupffer cell-restricted antigen presentation to antigen-specific CD8 T cells.

Authors:  Lynette Beattie; Adam Peltan; Asher Maroof; Alun Kirby; Najmeeyah Brown; Mark Coles; Deborah F Smith; Paul M Kaye
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

10.  Hepatic extracellular matrix alterations in dogs naturally infected with Leishmania (Leishmania) chagasi.

Authors:  Ferdinan Almeida Melo; Eliane Perlatto Moura; Raul Rio Ribeiro; Cíntia Fontes Alves; Marcelo Vidigal Caliari; Washington Luiz Tafuri; Kátia da Silva Calabrese; Wagner Luiz Tafuri
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.